A

Atara Biotherapeutics
D

ATRA

8.62000
USD
0.39
(4.74%)
مغلق
حجم التداول
454
الربح لكل سهم
3
العائد الربحي
-
P/E
-4
حجم السوق
51,387,190
أصول ذات صلة
C
CRVS
-0.03500
(-0.88%)
3.95500 USD
F
FATE
0.02000
(1.80%)
1.13000 USD
R
RCKT
0.04000
(1.39%)
2.92000 USD
R
RGEN
0.490
(0.39%)
127.440 USD
T
TXG
0.060
(0.46%)
13.060 USD
V
VKTX
0.430
(1.55%)
28.150 USD
المزيد
الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).